Trump says without proof that FDA 'deep state' slowing COVID trials

WASHINGTON (Reuters) - U.S. President Donald Trump on Saturday accused members of the 'deep state' at the Food and Drug Administration, without providing evidence, of working to slow testing of COVID-19 vaccines until after the November presidential election. In a Twitter post, Trump said the deep state 'or whoever' at the FDA was making it very difficult for drug companies to enroll people in clinical trials to test vaccines and therapies for the novel coronavirus.  The comment came after Reuters exclusively reported on Thursday that a top FDA official said he would resign if the Trump administration approved a vaccine before it was shown to be safe and effective

Reuters August 23, 2020 00:11:54 IST
Trump says without proof that FDA 'deep state' slowing COVID trials

Trump says without proof that FDA deep state slowing COVID trials

WASHINGTON (Reuters) - U.S. President Donald Trump on Saturday accused members of the "deep state" at the Food and Drug Administration, without providing evidence, of working to slow testing of COVID-19 vaccines until after the November presidential election.

In a Twitter post, Trump said the deep state "or whoever" at the FDA was making it very difficult for drug companies to enroll people in clinical trials to test vaccines and therapies for the novel coronavirus

The comment came after Reuters exclusively reported on Thursday that a top FDA official said he would resign if the Trump administration approved a vaccine before it was shown to be safe and effective.

"Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!" Trump wrote, tagging FDA Commissioner Stephen Hahn in the tweet.

Trump often uses Twitter to criticize federal agencies, sometimes accusing them of being controlled by the "deep state" in an apparent reference to long-serving staff who, in Trump's eyes, are determined to undermine his agenda.

His tweet increases the pressure on the FDA after Peter Marks, director of its Center for Biologics Evaluation and Research, last week said on a conference call with government officials, pharmaceutical executives and academics that he would resign if the agency rubber-stamped an unproven vaccine.

Scientists, public health officials and lawmakers are worried that the Trump administration will push the FDA to approve a vaccine in advance of the vote, even if data from clinical trials do not support its widespread use. Marks, whose division regulates cutting-edge biotech treatments, vaccines and gene therapies, told Reuters he has not faced any political pressure and that the FDA would be guided by science alone. Should that change, he said on Thursday, "I would feel obligated (to resign) because in doing so, I would indicate to the American public that there's something wrong."

(Reporting by Linda So; Editing by Daniel Wallis)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Pulitzer Prize-winning photojournalist Danish Siddiqui killed in Afghanistan: Politicans, journalists pay tributes
India

Pulitzer Prize-winning photojournalist Danish Siddiqui killed in Afghanistan: Politicans, journalists pay tributes

The Pulitzer prize winner, who was in Kandahar covering operations against Taliban, was killed when he was riding along with the Afghan Special Forces

Indian photojournalist Danish Siddiqui killed during assignment in Afghanistan's Kandahar province
India

Indian photojournalist Danish Siddiqui killed during assignment in Afghanistan's Kandahar province

Siddiqui had also covered the 2020 Delhi riots, COVID-19 pandemic, Nepal earthquake in 2015 and the protests in Hong Kong

Danish Siddiqui's passing is a reminder of the high price one pays for showing the truth
India

Danish Siddiqui's passing is a reminder of the high price one pays for showing the truth

Danish's photographs were not just documentation, but the work of someone who went down to eye-level, as they say in photographic parlance.